1 / 34

FLU Clinic Volunteer Orientation 2017-2018

Join Arkansas Department of Health for the Flu Clinic Volunteer Orientation. Learn about goals and objectives, receive necessary training, and help provide protection against influenza.

kdyck
Download Presentation

FLU Clinic Volunteer Orientation 2017-2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FLU Clinic Volunteer Orientation2017-2018 Arkansas Department of Health

  2. Goals and Objectives Provide protection against influenza Decrease Illness Decrease Absentees Decrease Spread of Disease Community Immunity Herd Immunity Cocoon Effect

  3. Nursing/Volunteers Non ADH and ADH Non-Clinical Attend orientation Non-ADH nurses Provide current Arkansas Nursing License Picture ID Sign Volunteer Indemnity form Sign HIPPA form

  4. Indications for flu vaccine Any person who wishes to reduce the likelihood of becoming ill or transmitting influenza Inactivated influenza vaccine can be given to anyone 6 months of age or older, including breastfeeding and pregnant women

  5. Recommendations All persons aged ≥ 6 months, unless medically contraindicated. Persons at higher risk for influenza-related complications

  6. People with asthma • People with diabetes • People with heart disease and those who have had a stroke • Adults 65 and older • Pregnant women • People who have HIV or AIDS • People who have Cancer • Children younger than 5, but especially children younger than 2 years old People at Increased Risk of Influenza Complications

  7. People Who are Transmission Sources Healthy household contacts and caregivers of: Children ages 0-59 months Persons > 50 years old Persons at high risk for severe complications from influenza

  8. Transmission Sources (cont.) Health Care Providers: People who provide home care to persons in groups at high risk People working in health-care settings include physicians, nurses, and other workers in hospitals, long term care facilities, assisted living and outpatient-care settings Medical emergency response workers Students in these professions who will have contact with patients

  9. To prevent transmission to those who are at high risk for influenza-related complications: Immunize the people who live with or care for them!

  10. Influenza Vaccine 2016-2017 The 2017-2018 Quadrivalent influenza vaccines contain the following influenza strains: A/Michigan/45/2015 (H1N1)pdm09-like virus; A/Hong Kong/4801/2014 (H3N2)-like virus; B/Brisbane/60/2008-like virus(B/Victoria lineage) B/Phuket/3073-like virus (B/Yamagata lineage)

  11. All ADH vaccine will be in pre-filled syringes. • All ADH vaccine will be preservative free and latex free.

  12. Vaccine Reactions Approximately 2 weeks after vaccination, antibodies develop Common reactions Soreness/erythema/induration at site lasting 1-2 days (15-20%) Fever/chills/malaise/myalgia lasting 1-2 days (<1%) Rare: immediate hypersensitivity allergic reactions (hives/angioedema/allergic asthma/systemic anaphylaxis)

  13. Age Group Dosage > 6 months FluLaval 0.5 mL IM* *Children 8 years and younger may need two doses administered at least 4 weeks apart

  14. Children aged 6 months through 8 years who are receiving influenza vaccine for the first time or those who have not received > 2 doses before July 1, 2017, require two doses of vaccine administered ≥ 4 weeks apart.

  15. Contraindications and Precautions: Contraindications: Severe allergic reaction to any component of the vaccine or after previous dose of any influenza vaccine. Precautions: Moderate to severe illness with or without fever; history of Guillain-Barre syndrome within 6 weeks of receipt of influenza vaccine * *requires a consultation with patient’s physician

  16. Local: Pain, tenderness, and redness at the injection site • Systemic: • Drowsiness • Headache • Irritability • Myalgia • Fatigue, arthralgia, GI symptoms, and loss of appetite have also been noted in children Side Effects/Adverse Reactions:FluLaval

  17. > 18 years of age 0.50ml • Utilized for ADH employees with serious, anaphylactic reaction to eggs • 10 doses available in each region and Central Office Flublok: Injectable

  18. Mass Flu Clinics

  19. Clinic Site A nursing coordinator will be at each clinic site for your assistance and can answer questions as needed Locate emergency kit/first aid station at each clinic site

  20. Clinic Flow Patient enters clinic/site Route to screening area Give current VIS (Vaccine Information Statement) Route to Data Intake area to complete Imm-Flu form Patient must sign and date Imm-Flu form Route patient to a nursing station with the Imm-Flu form for vaccination

  21. Forms Vaccine Information Statements (VIS) Arkansas Department of Health Influenza Season--Immunization Consent form (IMM-Flu form)

  22. Nursing Station Greet patient/collect Imm-Flu form Screen for contraindications/precautions- answer all questions Administer the indicated vaccine Complete the Imm Flu form and keep form Shot code Site/dosage/lot# Nurse signature Provide documentation of vaccination, if requested Route patient to exit

  23. Injection Technique

  24. Sites: • Infants: vastus lateralis (anterolateral thigh) • Young children over the age of 12 months-anterolateral aspect of the thigh may be used if the deltoid is underdeveloped • Adults and older children: deltoid (upper arm) Dosage: • 6 months and older : 0.5ml IM Vaccine Administration

  25. Determine the appropriate vaccine and injection site • Prep site with alcohol wipe/cotton ball • Using a circular motion, wipe the site with alcohol from center out and allow to dry • Attach the safety glide needle to the prefilled syringe Injection Technique

  26. Spread skin taut between thumb and forefinger OR grasp tissue and “bunch up” muscle (acceptable for pediatric and geriatric patients). • Insert needle fully into muscle at 90 degree angle and inject vaccine quickly. Injection Technique(cont.)

  27. Apply light pressure to injection site for several seconds with dry cotton ball or gauze • Dispose of syringe in sharps container Injection Technique (cont.)

  28. Injection Technique (cont.) USE OF VANISHPOINT SAFETY NEEDLES • ADH will be using VanishPoint safety needles for injections • Activate safety mechanism immediately after injection by pushing the color coded tab toward the safety chamber, allowing the needle to automatically retract into the safety chamber • Activate the safety mechanism away from self and others.

  29. Influenza vaccine should be stored at 36°F-46°F (2°C-8°C) • Temperatures should be documented every hour • Report out of range temperatures immediately • Keep storage unit container(s) closed as much as possible • No more then 10 doses of vaccine should be removed from the storage unit and prepared during an off site clinic • Discard any vaccine-filled syringes if the needles have been attached after the clinic closes Vaccine Management

  30. Good handwashing is recommended but if soap and water is not available, you may use alcohol-based waterless cleanser between each patient (available at each nursing station) Standard Precautions

  31. Gloves are not mandatory unless the provider has open lesion on hands. (Available at each nursing station) If latex free gloves are required, contact the nursing coordinator Standard Precautions (cont.)

  32. If a needle stick injury occurs-report it IMMEDIATELY to the nursing coordinator Needle Safety

  33. THANK YOU!

More Related